Health & Medicine

6
facebook twitter google print email
Media Contact:Katie Delach | katie.delach@uphs.upenn.edu | 215-349-5964March 26, 2015

Penn Medicine Experts Unveil Two New Ways to Identify Joint Replacement Patients at Risk for Post-Operative Complications

Orthopedic surgeons from the Perelman School of Medicine at the University of Pennsylvania have developed two new prediction tools aimed at identifying total hip and knee replacement patients who are at-risk of developing serious complications after surgery. The first tool identifies patients who have risk factors that should disqualify them from undergoing same-day (outpatient) or short-stay (overnight) total hip and knee replacement procedures, opting instead for traditional recovery pathways in the hospital.

facebook twitter google print email
Media Contact:Greg Richter | gregory.richter@uphs.upenn.edu | 215-614-1937March 26, 2015

Roseroot Herb Shows Promise as Potential Depression Treatment Option, Penn Team Finds

Rhodiola rosea (R. rosea), or roseroot, may be a beneficial treatment option for major depressive disorder (MDD), according to results of a study in the journal Phytomedicine led by Jun J. Mao, MD, MSCE, associate professor of Family Medicine, Community Health and Epidemiology and colleagues at the Perelman School of Medicine of University of Pennsylvania.

facebook twitter google print email
Media Contact:Katie Delach | katie.delach@uphs.upenn.edu | 215-349-5964March 26, 2015

Penn Medicine Study: In Debated Surgical Procedure, Technique Trumps Technology

A team of orthopedic surgeons from the Perelman School of Medicine at the University of Pennsylvania has found that modern technology for healing distal femur fractures is as safe and effective as its more established alternative, without a potential shortfall of the older approach.

Greening Vacant Lots in Philly Is Good for Your Heart [Before and After Photos]

March 23, 2015

Eugenia South of the Perelman School of Medicine talks about researching how walking by green spaces reduces stress.

facebook twitter google print email
Media Contact:Katherine Unger Baillie | kbaillie@upenn.edu | 215-898-9194March 24, 2015

New Penn Program Studies the Body’s Cells, One By One

blurb: 
The Penn Program in Single Cell Biology is a new effort by faculty members James Eberwine and Junhyong Kim to understand biology as it happens in each individual cell.

By Sarah Welsh

Cancer starts with a single cell going haywire. What is it about that one cell that makes it different from the rest, setting it on a path of destruction? A new program at the University of Pennsylvania may help find an answer to that and many other questions.

Weight Loss Doesn’t Always Lead to Happiness

March 23, 2015

Anthony Fabricatore of the Perelman School of Medicine is cited for his 2011 review of various weight-loss methods and

Article Source: Atlantic

Audio: Keynote Address at Royal College of Physicians

March 21, 2015

Flaura Winston of the Perelman School of Medicine is interviewed about ADHD and driving.

Article Source: Traffic Medicine
facebook twitter google print email
Media Contact:Anna Duerr | anna.duerr@uphs.upenn.edu | 215-349-8369March 23, 2015

Penn Medicine Experts Offer Suggestions for Nudging Children toward Healthier Food Choices

Strategies aimed at reducing childhood obesity should acknowledge individuals’ rational taste preferences and apply insights from behavioral economics to design choice architecture that increases their likelihood of success, say two physician-scientists from the Perelman School of Medicine at the University of Pennsylvania and the Center for Health Incentives and Behavioral Economics in an editorial published in JAMA Pediatrics.

facebook twitter google print email
Media Contact:Karen Kreeger | karen.kreeger@uphs.upenn.edu | 215-349-5658March 23, 2015

Penn Medicine: Genomewide Screen of Learning in Zebrafish Identifies Enzyme Important in Neural Circuit

Researchers at the Perelman School of Medicine at the University of Pennsylvaniadescribe the first set of genes important in learning in a zebrafish model in the journal Neuron this week. “Using an in-depth analysis of one of these genes, we have already revealed an important relevant signaling pathway,” says senior author Michael Granato, PhD, a professor of Cell and Developmental Biology. “The proteins in this pathway could provide new insights into the development of novel pharmacological targets.”

facebook twitter google print email
Media Contact:Lee-Ann Donegan | leeann.donegan@uphs.upenn.edu | 215-349-5660March 20, 2015

Penn Medicine Researchers Pinpoint Potential New Drug Target for Protection against Certain Neurodegenerative Diseases

Penn Medicine researchers have discovered that hypermethylation - the epigenetic ability to turn down or turn off a bad gene implicated in 10 to 30 percent of patients with Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Degeneration (FTD) - serves as a protective barrier inhibiting the development of these diseases.  Their work, published this month in Neurology, may suggest a neuroprotective target for drug discovery efforts.